Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-005179
Filing Date
2020-05-05
Accepted
2020-05-05 16:06:27
Documents
70
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q rigl-20200331x10q.htm 10-Q 2261431
2 EX-10.1 rigl-20200331ex1019ed5fb.htm EX-10.1 265778
3 EX-31.1 rigl-20200331ex311231187.htm EX-31.1 17789
4 EX-31.2 rigl-20200331ex312e3d048.htm EX-31.2 17779
5 EX-32.1 rigl-20200331ex321e2acf2.htm EX-32.1 9420
6 GRAPHIC rigl20200331x10q001.jpg GRAPHIC 41291
  Complete submission text file 0001558370-20-005179.txt   7782301

Data Files

Seq Description Document Type Size
7 EX-101.INS rigl-20200331.xml EX-101.INS 1585391
8 EX-101.SCH rigl-20200331.xsd EX-101.SCH 49556
9 EX-101.CAL rigl-20200331_cal.xml EX-101.CAL 50286
10 EX-101.DEF rigl-20200331_def.xml EX-101.DEF 173625
11 EX-101.LAB rigl-20200331_lab.xml EX-101.LAB 447243
12 EX-101.PRE rigl-20200331_pre.xml EX-101.PRE 319423
Mailing Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
RIGEL PHARMACEUTICALS INC (Filer) CIK: 0001034842 (see all company filings)

EIN.: 943248524 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-29889 | Film No.: 20848837
SIC: 2834 Pharmaceutical Preparations